SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around upcoming staking updates and airdrop details, creating excitement. The community buzzes about token burns, achieving new milestones, and the potential for future utilities. Brokecoin continues to gain traction within the Solana meme coin ecosystem, fueled by a dedicated community and ongoing development efforts.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending as chatter focuses on Donald Trump's alleged connections to the Epstein case, with community members debating the validity and implications of related documents. Some are defending Trump, claiming the accusations are a hoax, while others criticize his associations and economic policies. The stock's performance and broader economic concerns under the current administration are also being discussed.

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending as the community rallies around its strong performance within the Injective ecosystem and its potential for high gains. Bullish sentiment is fueled by the anticipation of a staked $INJ ETF, which some believe could drive further momentum for this memecoin. Community members are actively discussing its unique features, such as the burned liquidity pool, and its potential to outperform other meme coins.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

TROLL.X is trending following news of the Solana memecoin officially acquiring rights to the Trollface meme, leading to a surge in market cap. The community is discussing its potential for significant gains, drawing comparisons to other successful meme coins and highlighting its strong community. Some users are also pointing to $GASH.X as another coin with similar potential.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAL is trending as the community discusses its potential in early cancer detection, highlighted by a recent article and a story about its life-saving importance. Some traders are taking profits, anticipating a retest, while others see long-term potential, particularly with possible FDA approval and broader access to its Galleri test. Volume and news catalysts are key talking points for future price movement.

Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad’s CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Align Technology, Inc.

ALGN is trending as the community discusses recent price movement and future prospects, with some users drawing comparisons to SmileDirectClub's bankruptcy. Bullish investors point to share buybacks and insider buying as potential catalysts, while bears cite concerns about competition and market saturation. Discussions also include potential price targets and reactions to news from analysts.

WorldFinancial

World Liberty Financial (WLFI.X) is trending as the community discusses its potential role in revolutionizing finance, particularly through its USD1 stablecoin and tokenized real estate initiatives, with some highlighting potential conflicts involving Justin Sun. Community members are debating the token's long-term prospects, its ties to the Trump family, and its relationship with ALTS.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the U.S. Department of Commerce selected it to verify and distribute economic data onchain. The community is discussing its potential to disrupt the oracle space and integrate with DeFi protocols, drawing comparisons to Chainlink and CRO. Some users are speculating on price targets and anticipating the next leg up.

USELESS

$USELESS.X is gaining attention, with community members highlighting the potential for significant gains, referencing a possible 2000% move. Bullish sentiment seems to be driven by the coin's low market cap and community excitement around its potential, especially compared to other memecoins. Some users suggest that whales are accumulating $USELESS.X, anticipating a substantial pump.

Cyngn, Inc. engages in the development of autonomous driving software that can be deployed on multiple vehicle types in various environments. The company was founded by Kirt McMaster and Steve Kondik in 2013 and is headquartered in Mountain View, CA.

Cyngn Inc

CYN is trending due to a recent $300M mixed securities shelf offering, sparking concerns among investors about potential dilution and reverse stock splits. The community is actively discussing the implications of this offering, its effect on the stock's price, and the company's long-term financial stability. Despite a collaboration with NVIDIA, the stock's history of dilution and reverse splits remains a key point of discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates

Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates

MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates

Shares of Affimed N.V. (AFMD) were in the spotlight on Monday morning after the company received a notice from Nasdaq indicating a compliance issue with its stock price.Affirmed <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/04/21/3064526/0/en/Affimed-Announces-Receipt-of-NASDAQ-Deficiency-Notice-Regarding-Minimum-Bid-Price-Requirement.html">said</a> that the Nasdaq notice indicated the bid price for the company’s common shares had closed below the minimum $1.00 per share requirement for continued listing on the bourse.Affirmed, headquartered in Mannheim, Germany, stated that it has been granted an initial period of 180 calendar days, or until October 13, 2025, to regain compliance.The company said that if it fails to regain compliance with the Minimum Bid Price Rule during the period, it may consider applying to transfer its securities from The Nasdaq Global Select Market to The Nasdaq Capital Market, provided that it meets the requirements.Affirmed also added that there is no assurance that Nasdaq would grant the company’s request for continued listing in the case.In the meantime, the firm intends to monitor the bid price of its common shares and consider available options to regain compliance with the Minimum Bid Price Rule.Affimed is a clinical-stage company aimed at developing treatments for cancer. In December, the company announced positive updates from a trial of its AFM24 in combination with atezolizumab in Non-Small Cell Lung Cancer patients.AFM24 is an innate cell engager molecule that activates the innate immune system to kill cancer cells.On Stocktwits, retail sentiment regarding Affimed remained unchanged within ‘neutral’ territory over the past 24 hours, while message volume remained at ‘extremely low’ levels.<figure class="image"><img style="aspect-ratio:648/146;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_21_at_7_06_18_AM_png_68fb6a412b.webp" alt="AFMD's Sentiment Meter and Message Volume as of 7:20 a.m. ET on April 21, 2025 | Source: Stocktwits" width="648" height="146"><figcaption>AFMD's Sentiment Meter and Message Volume as of 7:20 a.m. ET on April 21, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/AFMD">AFMD stock</a> is down by about 46% so far this year and by over 85% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/dhl-freezes-shipments-worth-over-800-to-us-consumers-amid-rising-trade-tensions/chQiW2kRbQO">DHL Freezes Shipments Worth Over $800 To US Consumers Amid Rising Trade Tensions</a>For updates and corrections, email newsroom[at]stocktwits[dot]com&nbsp;

Global stock market chart and trading board - stock photo

Affimed Receives Nasdaq Deficiency Notice Over Low Share Price: Retail’s In Wait-And-Wait Mode

The company has been granted an initial period of 180 calendar days, or until October 13, 2025, to regain compliance with Nasdaq’s Minimum Bid Price Rule.

Equity

Q4 2023 Affimed NV Earnings Call Transcript

Affimed Reports 2023 Financial Results and Operational Progress

AFM24 combination with atezolizumab (AFM24-102): Follow-up of the Phase 1/2a combination study confirmed four responses in the non-small cell cancer (NSCLC) EGFR-wildtype cohort: one complete...

Aper u : B n fices de Affimed

Affimed (NASDAQ:AFMD) va annoncer ses derniers b n fices ce jeudi. Suivez les tendances du march , avec l'aper u des b n fices du quatri me trimestre de Affimed de Benzinga.
R sultat net, b n fices...

Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024

MANNHEIM, Germany, March 21, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) ( Affimed or the Company ), a clinical-stage immuno-oncology company committed to giving patients back their...

Affimed Announces 1-for-10 Reverse Stock Split

MANNHEIM, Germany, March 06, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) ( Affimed or the Company ), a clinical-stage immuno-oncology company committed to giving patients back their...

Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer

Data update from AFM24-102 Phase 1/2a combination study includes 15 heavily pre-treated patients from the EGFR-wildtype (wt) non-small cell lung cancer (NSCLC) expansion cohortFollow-up shows three...

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.

AFMD
Affimed N.V.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AFMD News

AFMD Affimed N.V.